E-monitoring to increase treatment quality and functional capacity in young rheumatoid arthritis patients with high disease activity

Not Applicable

Recruiting

Conditions: M08.8
M08.3
M08.4
Other juvenile arthritis
Juvenile polyarthritis (seronegative)
Pauciarticular juvenile arthritis

Registration Number: DRKS00034589

Lead Sponsor: Technische Universität München, TUM School of Medicine and Health, Department Sport and Health Sciences, Professur für Biomechanik im Sport

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 185

Inclusion Criteria

Diagnosis of JIA according to ILAR criteria

active JIA disease

at least moderate disease activity according to cJADAS10 (clinical Juvenile Arthritis Disease Activity Score for 10 joints;>1.5 for oligoarthritis; >2.5 for polyarthritis)

PWC test feasible

German-speaking

written consent for study participation (patient and parent/guardian)

access to digital devices (smartphone, tablet)

Exclusion Criteria

Non-infectious fever lasting more than 5 days and/or systemic JIA

Neurological, cardiac, orthopaedic, metabolic or pulmonary disease limiting physical activity

Pregnancy / breastfeeding

Chronic pain disorder

Simultaneous participation in behavioral or exercise therapy intervention studies

Simultaneous participation in a pharmaceutical intervention study

Due to language or mental barriers, patients and/or their relatives are unable to understand the study content and the information provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint of the study is the change in endurance capacity (Physical Working Capacity (PWC) 170 test). The parameters are recorded at the measurement points in the clinic (t0, t1).

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints are the tolerability and safety (inflammatory activity, pain) of the intervention and the health-related quality of life. The parameters are collected at the measurement points in the clinic (t0, t1) and at home in the period in between (t0-t1) and some are also collected afterwards (t2). For this purpose, clinical parameters and subjective parameters are used in a patient survey.